Brief: Sk Bioscience Announces Approval Of Its Quadrivalent Influenza Vaccine In Indonesia
23/10/2024 13:54
Oct 23 (Reuters) - SK Bioscience Co Ltd 302440.KS :
* SK BIOSCIENCE ANNOUNCES APPROVAL OF ITS QUADRIVALENT
INFLUENZA
VACCINE IN INDONESIA
Source text for Eikon: ID:nPnmz2wsa
Further company coverage: 302440.KS
((Reuters.Briefs@thomsonreuters.com))
Recent news on SK bioscience
See all newsBrief: Sk Bioscience Co Wins 23.9 Billion Won Order
Brief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate